Your browser doesn't support javascript.
loading
Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference?
Skutle, Arvid; Bu, Eli Torild Hellandsjø; Jellestad, Finn Konow; van Emmerik-van Oortmerssen, Katelijne; Dom, Geert; Verspreet, Sofie; Carpentier, Pieter Jan; Ramos-Quiroga, Josep Antoni; Franck, Johan; Konstenius, Maija; Kaye, Sharlene; Demetrovics, Zsolt; Barta, Csaba; Fatséas, Melina; Auriacombe, Marc; Johnson, Brian; Faraone, Stephen V; Levin, Frances R; Allsop, Steve; Carruthers, Susan; Schoevers, Robert A; Koeter, Maarten W J; van den Brink, Wim; Moggi, Franz; Møller, Merete; van de Glind, Geurt.
Afiliación
  • Skutle A; Bergen Clinics Foundation, Bergen, Norway.
  • Bu ETH; Bergen Clinics Foundation, Bergen, Norway.
  • Jellestad FK; Department of Biological and Medical Psychology, University of Bergen, Norway.
  • van Emmerik-van Oortmerssen K; Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Dom G; The Netherlands Arkin, Amsterdam, The Netherlands.
  • Verspreet S; Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium.
  • Carpentier PJ; Collaborative Antwerp Psychiatry Research Institute (CAPRI, UA), PC Alexian Brothers, Boechout, Belgium.
  • Ramos-Quiroga JA; Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands.
  • Franck J; Servei de Psiquiatria, Hospital Universitari Vall d'Hebron, CIBERSAM, Department of Psychiatry, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Konstenius M; Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden.
  • Kaye S; Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden.
  • Demetrovics Z; National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia.
  • Barta C; Institute of Psychology, Eötvös Loránd University, Budapest, Hungary.
  • Fatséas M; Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary.
  • Auriacombe M; Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France.
  • Johnson B; Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France.
  • Faraone SV; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Levin FR; Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Allsop S; Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Carruthers S; Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Schoevers RA; Columbia University/the New York State Psychiatric Institute, New York, USA.
  • Koeter MWJ; National Drug Research Institute/Curtin University of Technology, Perth, Australia.
  • van den Brink W; National Drug Research Institute/Curtin University of Technology, Perth, Australia.
  • Moggi F; Dept of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Møller M; Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • van de Glind G; Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Addict Behav Rep ; 2: 13-18, 2015 Dec.
Article en En | MEDLINE | ID: mdl-29531989
ABSTRACT

INTRODUCTION:

The prevalence of ADHD among patients with substance use disorder (SUD) is substantial. This study addressed the following research questions Are early developmental, temperamental and educational problems overrepresented among SUD patients with ADHD compared to SUD patients without ADHD? Do this comorbid group receive early help for their ADHD, and are there signs of self-medicating with illicit central stimulants?

METHOD:

An international, multi-centre cross-sectional study was carried out involving seven European countries, with 1205 patients in treatment for SUD. The mean age was 40 years and 27% of the sample was female. All participants were interviewed with the Mini International Neuropsychiatric Interview Plus and the Conners' Adult ADHD Diagnostic Interview for DSM-IV.

RESULTS:

SUD patients with ADHD (n = 196; 16.3% of the total sample) had a significantly slower infant development than SUD patients without ADHD (n = 1,009; 83.4%), had greater problems controlling their temperament, and had lower educational attainment. Only 24 (12%) of the current ADHD positive patients had been diagnosed and treated during childhood and/or adolescence. Finally, SUD patients with ADHD were more likely to have central stimulants or cannabis as their primary substance of abuse, whereas alcohol use was more likely to be the primary substance of abuse in SUD patients without ADHD.

CONCLUSION:

The results emphasize the importance of early identification of ADHD and targeted interventions in the health and school system, as well as in the addiction field.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Addict Behav Rep Año: 2015 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Addict Behav Rep Año: 2015 Tipo del documento: Article País de afiliación: Noruega